Perspectives in the investigation of Cockayne syndrome group B neurological disease:the utility of patient-derived brain organoid models
- Author:
WANG XINTAI
1
;
ZHENG RUI
;
DUKHINOVA MARINA
;
WANG LUXI
;
SHEN YING
;
LIN ZHIJIE
Author Information
- Keywords: Cockayne syndrome; Cockayne syndrome group B(CSB); Neurological function; Cerebellum; Organoids
- From: Journal of Zhejiang University. Science. B 2024;25(10):878-889,中插12-中插17
- CountryChina
- Language:Chinese
- Abstract: Cockayne syndrome(CS)group B(CSB),which results from mutations in the excision repair cross-complementation group 6(ERCC6)genes,which produce CSB protein,is an autosomal recessive disease characterized by multiple progressive disorders including growth failure,microcephaly,skin photosensitivity,and premature aging.Clinical data show that brain atrophy,demyelination,and calcification are the main neurological manifestations of CS,which progress with time.Neuronal loss and calcification occur in various brain areas,particularly the cerebellum and basal ganglia,resulting in dyskinesia,ataxia,and limb tremors in CSB patients.However,the understanding of neurodevelopmental defects in CS has been constrained by the lack of significant neurodevelopmental and functional abnormalities observed in CSB-deficient mice.In this review,we focus on elucidating the protein structure and distribution of CSB and delve into the impact of CSB mutations on the development and function of the nervous system.In addition,we provide an overview of research models that have been instrumental in exploring CS disorders,with a forward-looking perspective on the substantial contributions that brain organoids are poised to further advance this field.
